Director, Global Health Economics Lead, Oncology Business Unit

As a Director, Global Health Economics Lead, Oncology Business Unit, you will drive and realize value demonstration strategies for Takeda's global oncology portfolio, achieving rapid, broad patient access and delivering differentiated, evidence-based pricing through best-in-class health technology assessment (HTA) and payer decision outcomes.

Requirements

• Doctorate with 7+ years of experience, Master's with 9+ years of experience or Bachelor's with 12+ years of experience in healthcare industry with direct experience in global product value proposition development (industry or consulting) and interaction with payers, HTA bodies, relevant policymakers and strong patient-centered focus
• Robust understanding of the global payer environment and in-depth understanding of ex-US payer landscape including HTA trends and guidance (e.g., NICE, CADTH, PBAC, EU JCA), along with knowledge of US Medicare (Part D), ICER in the US and trends in Emerging Markets (e.g., China) – including reimbursement methodologies, pricing/reimbursement authorities' decision-making process and current reimbursement issues
• Strong knowledge and hands on experience in health economics, health technology assessment (HTA) tools, methods and filings, SLRs, ITCs, statistical analyses and economic modelling
• Strong knowledge and understanding of clinical and epidemiological information, innovative global pricing models, all phases of drug development methods of analysis of large databases (e.g., claims data, electronic health records) and the major areas of Outcomes Research (PROs, modelling)

Benefits

• Medical, dental, vision insurance
• 401(k) plan and company match
• Short-term and long-term disability coverage
• Basic life insurance
• Tuition reimbursement program
• Paid volunteer time off
• Company holidays
• Well-being benefits